Last reviewed · How we verify
NCT04025398: REHABILITUS
A Computer-based Cognitive Remediation Program for Adults With Intellectual Disability
NA trial testing Cognitive remediation program in Intellectual Disability in 116 participants. Currently enrolling.
17 June 2026
Quick facts
| Lead sponsor | Hôpital le Vinatier |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 116 |
| Start date | 17 June 2020 |
| Primary completion | 17 June 2026 |
| Estimated completion | 31 December 2026 |
| Sites | 1 location across France |
Drugs / interventions tested
- Cognitive remediation program
- Control group — full drug profile →
Conditions studied
- Intellectual Disability — all drugs for Intellectual Disability →
Sponsor
Hôpital le Vinatier — full company profile →
Who can join
Adults 18 to 45, any sex, with Intellectual Disability. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Adults with intellectual disabilities have great difficulty in adapting to social situations and relationships. Cognitive impairment associated with intellectual disability are important factors to understand their difficulties in processing social information. In the field of recognition of facial emotions in particular, basic cognitive processes such as visuospatial and attentional functions, are heavily involved. Cognitive remediation is a management tool widely used by practitioners to help patients who experience cognitive difficulties. Currently, no program can meet specific and validated the problems are adults with intellectual disabilities manner in their daily functioning
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04025398
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Cognitive remediation program
Trials testing the same drug.
- NCT04808674 — Remediation for Mild Cognitive Deficits After Cancer · NA · unknown
- NCT03284060 — Social Cognition Training and Cognitive Remediation · NA · terminated
- NCT02797418 — "Cognitus & Moi": a New Cognitive Remediation Tool · NA · terminated
Other recruiting trials for Intellectual Disability
Currently open trials in the same condition.
- NCT05473429 — Characterization of Nociception Phenotype in Individuals With Intellectual Disability · NA · recruiting
- NCT07497035 — Equine Therapy Programme on Stress, Autonomy and Balance in School-age Children With Intellectual Disabilities · NA · active not recruiting
- NCT07059858 — Bladder and Bowel Functions, Participation and Quality of Life in Children With Intellectual Disabilities · recruiting
- NCT07278544 — Harnessing Communication Preferences · NA · recruiting
- NCT06829264 — Testing an Evidence-Based Supported Employment Model in Autistic Young Adults · NA · recruiting
Other Hôpital le Vinatier trials
Trials by the same sponsor.
- NCT07428200 — Characterization of the Neural Bases of Mental Imagery in Individuals With Borderline Personality Disorder: An EEG Study · NA · not yet recruiting
- NCT07384819 — Duration of Moment in Autism · NA · not yet recruiting
- NCT06284382 — Interaction Between Early Trauma and Odor-induced Dopamine Release · NA · not yet recruiting
- NCT07119671 — Peer-aid and Hope Box · NA · not yet recruiting
- NCT06869915 — Homelessness and Prevalence of Neurodevelopmental Disorders · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04025398 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hôpital le Vinatier
- Last refreshed: 31 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04025398.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing